Pages that link to "Q73786557"
Jump to navigation
Jump to search
The following pages link to Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation (Q73786557):
Displaying 8 items.
- High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients. (Q33950015) (← links)
- Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and mu (Q36608468) (← links)
- A Phase 3, Randomized, Placebo-controlled Trial of Filgrastim in Patients with Haematological Malignancies Undergoing Matched-related Allogeneic Bone Marrow Transplantation (Q37262618) (← links)
- Optimal use of G-CSF administration after hematopoietic SCT. (Q37442645) (← links)
- The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis (Q45869164) (← links)
- Leukocyte cell population analysis from the coulter automatic blood cell analyzer DxH800 to monitor the effect of G-CSF. (Q46113354) (← links)
- Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantation (Q81326756) (← links)
- Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation (Q90463763) (← links)